HPLC HbA1c Glycosylated Hemoglobin Analyzer 378mm×380mm×510mm

HbA1c Testing Analyzer LD-560 Most Cost-effecive Hematology Detection Analyzer With HPLC Method

Intended Use

This analyzer is a fully automated instrument used to analyze glycosylated hemoglobin. It has the characteristics of small sample amount and simple operation. It is suitable for the detection of glycosylated hemoglobin in medical institutions. And the LD-560 analyzer has fully automatic system which is very easy for use. About the LD-560 it used in conjunction with suitable reagents for the quantitative detection of glycosylated hemoglobin (HbA1c) in human blood.

Specifications

Feature

• No Sample Pre-treatment
• Fully automated operation saves time and labor
• Automatic Primary tube sampling with cap puncture
• No special tools required for daily maintenance
• Reliable Results

Advantage

• Easy-to-use touch-screen platform,multi-language system
• Testing time within 90s per test
• Low cost and large sampling capacity
• Excellent precision, reliability and repeatability

Performance Parameters

• Reporting unit: Glycosylated hemoglobin (HbA1c) is reported in NGSP (%) and IFCC units (mmol/mol).
• Repeatability: For samples with a test concentration of 4%-6%, the sample coefficient of variation (CV) of the test results is not greater than 2.0%..
• The temperature accuracy and fluctuation of the chromatography column module: the temperature is within ±1°C of the set value, and the fluctuation is not more than 0.8°C.
• Accuracy: The accuracy is tested with reference materials as samples, and the relative deviation of the test results should be within ±5%.

Certificated

Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagents, electrolyte reagents, wash solution and urine test reagents.

Labnovation products are developed in house, tested extensively in clinics and passed strict quality controls. All of our products are CE marked and approved by SFDA. In the past 15 years, our products have been exported to 110 different countries and used in 8000 hospitals worldwide. We provide both ready-to-use final products and bulk OEM reagents, including ready-to-use reagents, concentrated, and powder.

With an investment of 10% of our annual sales into R&D, we release new products every years. We win more and more domestic and international cooperation by company reputation and products quality while we actively take part in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we are well-known by the companies in this field.